The Chairman, National Commission for Minorities, Shri Iqbal Singh Lalpura holds a meeting of the Commission in New Delhi


The monthly meeting of the National Commission for Minorities was held today  under the chairmanship of Shri Iqbal Singh Lalpura, Chairman. The Vice-Chairman and members of the Commission were present during the meeting along with all senior officers. Important issues with respect to the Commission were  discussed during the meeting.



From 30th  June, 2022 to 20th September, 2022, NCM has received 511 petitions out of which 317 have been disposed off.  In remaining 194 cases, action has been initiated and reports have been called /are at present at different levels of submission.


During the same period from 30th  June to 20th September, 2022, National Commission for Minorities held hearing for 13 cases and gave  suitable direction to the concerned to resolve the issues at the earliest.






(Release ID: 1861258)
Visitor Counter : 334











EC Healthcare Chairman Mr. Eddy Tang Further Increases Shareholding, Exhibiting Unwavering Assurance in the Future Development of the Group

EC Healthcare (the “Company”, which together with its subsidiaries is referred to as the “Group”, SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that on 7 September 2022, the Group’s Chairman, Executive Director and Chief Executive Officer Mr. Tang Chi Fai further acquired a total of 170,000 shares of the Company on the open market for approximately HK$854,800 at an average price of HK$5.0282 per share. Prior to this transaction, Mr. Tang had already increased his shareholding in the Company earlier this month on 1 September 2022, acquiring a total of 107,000 shares at an average price of $5.4905 per share. After the transaction, Mr. Tang holds an aggregate of 722,204,610 shares in the Company, increasing his equity stake from 61.27% to 61.29%.

Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, “In spite of the current economic climate, we are confident that the medical market will remain resilient and that long-term public-private healthcare partnerships will continue to drive up investment in Hong Kong’s private healthcare sector. Reaping the benefits from its ongoing investments in elevating healthcare service offerings, the Group exemplified solid business recovery by delivering first-quarter sales volume of no less than HK$860 million for the financial year that concluded on March 31, 2023. Management is still nevertheless upbeat about the Group’s business success going forward. In order to continue enhancing EC Healthcare’s enclosed healthcare ecosystem, the Group will go forward with its close collaboration with the major players in the technology, telecommunications, insurance, property, and pharmaceutical industries.”

About EC Healthcare
EC Healthcare is Hong Kong’s largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group’s high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism.

The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, primary care clinics jointly established with Tencent Doctorwork, chiropractic services centre New York Spine and Physiotherapy Center NYMG, health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, a comprehensive dental centre EC DENTAL CARE, a diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic SPECIALISTS CENTRAL, NEW MEDICAL CENTER and Prime Medical Centres, obstetrics and gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, specialists central, a paediatric center PRIME CARE, cardiology center HONG KONG INTERNATIONAL CARDIOLOGY CENTER, PathLab Medical Laboratories, a professional hair care center HAIR FOREST, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.

*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021






Topic: Press release summary

EC Healthcare Chairman Mr. Eddy Tang Increases Shareholding, Demonstrating Full Confidence in the Group’s Future Development

EC Healthcare (the “Company”, which together with its subsidiaries is referred to as the “Group”, SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that on 1 September 2022, the Group’s Chairman, Executive Director and Chief Executive Officer Mr. Tang Chi Fai had acquired a total 107,000 shares of the Company on the open market for approximately HK$587,000 at an average price of HK$5.4905 per share. After the transaction, Mr. Tang holds an aggregate of 722,034,610 shares in the Company, increasing his equity stake from 61.26% to 61.27%.

Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, “Benefitting from the result of its continuous investment in IT, brand and service, the Group recorded a sales volume of no less than HK$860 million in the first quarter of the financial year ended 31 March 2023 (April to June 2022). This shows a good recovery in its business. EC Healthcare will continue to consolidate the healthcare market through organic growth and acquisitions and thus reinforce its leading market position. The Group believes that the medical market will remain resilient in the challenging business environment and that public-private partnerships in healthcare will keep boosting spending in the market of Hong Kong’s private healthcare sector in the long run. Looking ahead, the management remains optimistic about the Group’s business performance. The Group will also forge ahead with its deep cooperation with the key players in the technology, telecommunications, insurance, property, and pharmaceutical industries so as to keep enriching EC Healthcare’s enclosed healthcare ecosystem.”

About EC Healthcare
EC Healthcare is Hong Kong’s largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group’s high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism.

The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, primary care clinics jointly established with Tencent Doctorwork, chiropractic services centre New York Spine and Physiotherapy Center NYMG, health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, a comprehensive dental centre EC DENTAL CARE, a diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic SPECIALISTS CENTRAL, NEW MEDICAL CENTER and Prime Medical Centres, obstetrics and gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, specialists central, a paediatric center PRIME CARE, cardiology center HONG KONG INTERNATIONAL CARDIOLOGY CENTER, PathLab Medical Laboratories, a professional hair care center HAIR FOREST, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.

*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021

For further information, please contact:
iPR Ogilvy Limited
Callis Lau / Lorraine Luk / Charmaine Ip
Tel: (852) 2136 6952 / 2169 0467 / 3920 7649
Fax: (852) 3170 6606
Email: ech@iprogilvy.com






Topic: Press release summary

Chairman and CEO/Railway Board inaugurates Iconic Week Celebrations of ‘Azadi Ki Rail Gadi aur Stations’


Chairman & CEO, Railway Board, Shri Vinay Kumar Tripathi inaugurated the Iconic Week Celebrations of the ‘Azadi Ki Rail Gadi aur Stations’ today in Rail Bhawan. Highlighting the importance of 75 identified stations/27 trains in the freedom struggle, Indian Railways will organize week long celebrations from 18th July-23rd July.



Speaking on the occasion, Shri Vinay Kumar Tripathi said, “As a part of the Azadi Ka Amrit Mahotsav, the event ‘Azadi Ki Rail Gadi aur Stations will be held during this week called as Iconic Week, under the overall spirit of Jan Bhagidari and Jan Andolan, which will showcase the convergence of the values and glories of the freedom struggle of the past with the aspirations and dreams of a young, new and iconic India. This week will culminate with the Milestone function on 23rd July 2022.”



The events of this Iconic Week celebration are focussed both on the Railway Stations and Trains having historical importance. For this, 75 Railway Stations have been identified as Freedom Stations and 27 Trains for Spot Lighting. In all these 75 Stations across 24 states, besides lighting up and decorations, events such as Nukkad Natak in local language, light and sound shows, display of video films/ patriotic songs, etc would be held, with a view to increase the outreach of Janbhagidari. Photo Exhibition and Selfie Point in the backdrop of ‘Azadi Ki Rail Gadi’ would be set up and remain in these Station premises during the entire iconic week event. On the day of the Milestone Function in Delhi on 23rd July 22, family members of Freedom Fighters from the respective local area will be invited to the Stations to share their story.  


Under the programme Spot Lighting of Trains, 27 identified trains will be flagged off by Freedom Fighter’s family from the originating stations. These trains will be appropriately decorated and historical facts about the trains would be depicted for the benefit of our citizens, particularly the younger generation.


The Iconic Week Celebration will be very impactful across the country and more vibrant around the Freedom Stations & Spotlight Trains to kindle the patriotic spirit in the minds of travelling public and people at large.


***


RKJ/M




(Release ID: 1842406)
Visitor Counter : 818











Hong Kong – FDC Chairman expresses condolences over passing of Mr Alex Law Kai-yui

FDC Chairman expresses condolences over passing of Mr Alex Law Kai-yui

**********************************************************************


The following is issued on behalf of the Hong Kong Film Developmrent Council:



     The Chairman of the Hong Kong Film Development Council (FDC), Dr Wilfred Wong Ying-wai, today (July 3) expressed deep sorrow over the passing of famous film director Mr Alex Law Kai-yui.



     Mr Wong said, “Alex is a leading figure in the development of the local film industry. Being an outstanding Hong Kong film director, he had earned a lot of achievement throughout his career. He had also contributed a lot to the local film industry. He was member of the FDC from 2013 to 2015. Being the Chairman of the FDC, I am particularly impressed by Alex’s enthusiasm to support the programmes launched by the FDC. He joined the Directors’ Succession Scheme in order to pass his exceptional directing knowledge and experiences to the younger generation. He also helped assess the works of the Scriptwriting Incubation Programme and First Feature Film Initiative for identifying screenwriting talents and new directors. His departure is a huge loss for the local film industry and he will be truly missed.”